Navigation Links
TetraQ recognized for toxicology services
Date:5/16/2008

TetraQ, the integrated preclinical contract research provider based at The University of Queensland (UQ), has attained Good Laboratory Practice (GLP) recognition for its toxicology services after satisfying rigorous internationally-benchmarked criteria.

The additional accreditation from the National Association of Testing Authorities (NATA) for another of its key laboratories means that as well as GLP bioanalytical services, TetraQ can provide local and international clients with GLP compliant toxicology services including genotoxicity, dose range-finding, acute and repeat-dose studies.

TetraQ's Executive Director, Professor Maree Smith, said the GLP accreditation for its toxicology and ADME laboratories had now positioned TetraQ as the leading integrated preclinical service provider to the Australian biopharmaceutical industry.

TetraQ's decision to offer toxicology services, including toxicokinetics, allows us to leverage our strong track record in fully-validated bioanalytical method development and sample analysis, Professor Smith said.

We are delighted to be able to offer our clients in Australia and overseas an extended, internationally accredited service delivery which includes acute and chronic toxicology services, said Professor Smith.

These toxicology services include cytotoxicity assays, genotoxicity assays - bacterial mutation (Ames) tests; mouse lymphoma assay; mammalian erythrocyte micronucleus testing; dose range finding; safety pharmacology (cardiovascular, central nervous and respiratory systems); off-target screening; and hERG binding assays.

TetraQ has state-of-the-art facilities and equipment which meet stringent quality and testing standards to conduct toxicology studies that can be recognized by international regulatory authorities.

GLP recognition is required for regulatory submissions on later-stage toxicology studies, and because we have designed our early-stage services to generate data that will provide valuable input into the planning of more expensive and extensive GLP regulatory studies, we can offer clients a stream-lined suite of screening services. We can also interpret and provide advice on toxicology reports our clients have received from other contract research organisations, Professor Smith said.


'/>"/>

Contact: Rose-Marie Pennisi
communications@uq.edu.au
61-733-467-374
Research Australia
Source:Eurekalert

Related medicine news :

1. Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency
2. Health Advocate Recognized by Inc. 500 as One of the Nations Fastest Growing Private Companies
3. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
4. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
5. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
6. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
7. J.D. Power and Associates Reports: Rush-Copley Medical Center Recognized for Third Consecutive Year for Providing an Outstanding Inpatient Experience
8. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
9. Blue Cross and Blue Shield Association Nationally Recognized by BusinessWeek and AARP for Creating a Unique Workplace Environment for New and Mature Employees
10. Higher death rates in kidney patients with newly recognized disease
11. For Second Year Beryl Recognized as a Tech Titan, One of Texas Fastest- Growing Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Journal of Oral Implantology ... have severe consequences to overall dental health, including complications with speech, eating, and overcompensation ... dental implants to replace lost teeth. As the number of tooth replacements increase, it ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... Hackensack, N.J. has been honored by Enterprising Women magazine as one of its ... world’s top women business owners. Winners have demonstrated that they have fast-growth businesses, ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... RawTrition now ... easy way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients ... the cellular level because the body recognizes its raw form (unlike the synthetically made ...
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and ... its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... , April 24, 2017 Solentim, the ... announced the addition of a major new product ... Plate Seeding,). The VIPS has been developed for ... well microplates as part of the process to ... a simple and more reliable solution when compared ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: